Neoadjuvant capecitabine (X), docetaxel (T)±trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC): preliminary safety and efficacy data from a multicentre phase II study

✍ Scribed by W. Lybaert; Wildiers; P. Neven; P. Clement; M.R. Christiaens; C. Weltens; R. Drijkoningen; C. Van Ongeval; A. Van Steen; R. Paridaens

• Book ID: 118624673
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 258 KB
• Volume: 4
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(06)80394-0